Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer

Kenzo Soejima, Hiroyuki Yasuda, Toshiyuki Hirano

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint Dive into the research topics of 'Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences